STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

DFFN DIFFUSION PHARMACEUTICALS INCORPORATED StockScouter® Report

3

StockScouter® Score

DIFFUSION PHARMACEUTICALS INCORPORATED, a micro cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive

 

Concerns

  • The 50-day moving average for DFFN is significantly below its 200-day moving average. Negative
  • Short-term relative price momentum exhibits meaningful weakness. Negative
  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 100% done.
Progress: 40% done.
Low
High

Core Model Grades

B
N/A
N/A
F

Previous Ratings

3
1
4